The online version of this article (doi:10.1186/1475-2875-11-34) contains supplementary material, which is available to authorized users.
Donald L Gardiner and Katharine R Trenholme contributed equally to this work.
The authors declare that they have no competing interests.
DLG, KRT and DL conceived the study, DLG, KRT and CLP designed the study, undertook the experimental procedures and data analysis. All authors participated in interpretation of the data. KRT drafted the final manuscript, which was read and approved by all authors.
Recent renewed emphasis on the eradication of malaria has highlighted the need for more tools with which to achieve this ambitious goal. One high priority area is the need to determine the gametocytocidal activity of both currently used anti-malarial drugs and those in the development pipeline. However, testing the activity of compounds against Plasmodium falciparum gametocytes is technically challenging both in vivo and in vitro.
Here the use of a simple robust assay to screen a panel of currently used and experimental anti-malarial drugs against mature P. falciparum gametocytes is described.
Eight of 44 compounds tested reduced gametocyte viability by at least 50% and three showed IC50 values in nM range.
There is a need to identify new compounds with activity against late stage gametocytes and the information provided by this in vitro assay is a valuable first step, which can guide future clinical studies.
Authors’ original file for figure 112936_2011_1998_MOESM1_ESM.tiff
Darling ST: Studies in relation to malaria. Isthmanian Canal Commission 1910. 1910, Washington D.C.: Laboratory of the Board of Health, Istmanian Canal Commission, 3-38.
Lang-Unnasch N, Murphy AD: Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. Ann Rev Microbiol. 1998, 52: 561-590. 10.1146/annurev.micro.52.1.561. CrossRef
Williams JL: Stimulation of Plasmodium falciparu gametocytogenesis by conditioned medium from parasite cultures. Am J Trop Med Hyg. 1999, 60: 7-13. PubMed
Kariuki MM, Kiaira JK, Mulaa FK, Mwangi JK, Wasunna MK, Martin SK: Plasmodium falciparum: purification of the various gametocyte developmental stages from in vitro-cultivated parasites. Am J Trop Med Hyg. 1998, 59: 505-508. PubMed
The malERA Consultative Group on Drugs: A research agenda to underpin malaria eradication. PLoS Med. 2011, 8: e10003978- CrossRef
Kiszewski AE: Blocking Plasmodium falciparum malaria transmission with drugs. Pharmaceutical. 2011, 4: 44-68.
Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, Meissner PE, Muller O: Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomized controlled trial. PLOS One. 2009, 4: e5318-10.1371/journal.pone.0005318. PubMedCentralCrossRefPubMed
Bates MD, Meshnick SR, Sigler CI, Leland P: In vitr effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghe. Am J Trop Med Hyg. 1990, 42: 532-327. PubMed
- Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
Christopher L Peatey
Donald L Gardiner
Katharine R Trenholme
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II